Does Urolithin A Boost NAD+?
Short answer: urolithin A is not a NAD+ booster in the way NMN and NR are, and it would be misleading to market it as one. It works on a completely different part of the cell. Here is what that distinction actually means, and why it matters when you're deciding what to take.
Why people ask this question
NAD+ (nicotinamide adenine dinucleotide) and urolithin A both live in the "cellular energy and longevity" corner of the supplement world, and both are tied to mitochondria, so it's natural to assume they do similar jobs. They don't. NAD+ is a molecule your cells use directly in energy metabolism and in hundreds of enzyme reactions. Urolithin A is a food-derived postbiotic studied for how it affects mitochondrial recycling. Lumping them together is one of the most common misunderstandings in this category, and getting it straight will save you money and disappointment.
What NAD+ is and how you actually raise it
NAD+ is a coenzyme present in every cell. It shuttles electrons during metabolism and is consumed by enzymes involved in DNA repair and cellular signaling. NAD+ levels are widely reported to decline with age, which is why "boosting NAD+" became a popular goal. The compounds most directly associated with raising NAD+ are its precursors — molecules the body converts into NAD+ through known biochemical steps. The best known are NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside). When you take those, you are supplying raw material the NAD+ salvage pathway can use. That is a direct, precursor-based mechanism. For a fuller treatment, see our explainer on what NAD+ is.
What urolithin A does instead
Urolithin A does not sit in the NAD+ synthesis pathway. It is not a precursor, and it does not get converted into NAD+. Its studied mechanism is mitophagy — the cell's targeted system for identifying damaged, inefficient mitochondria and breaking them down so their components can be reused and replaced. The foundational preclinical research by Ryu and colleagues (Nature Medicine, 2016) showed in roundworms and rodents that urolithin A induced mitophagy and improved markers of muscle function. We flag that as preclinical — animal and cell models that establish the mechanism, not proof of an identical effect in people.
So the two approaches sit at different points in the system. NAD+ precursors are about supplying a working molecule the cell burns through. Urolithin A is about improving the quality of the machinery — the mitochondria themselves — by helping clear out the broken units. One is fuel and cofactor; the other is maintenance. That is why calling urolithin A a "NAD+ booster" is simply inaccurate, however appealing the shorthand might be.
Could urolithin A affect NAD+ indirectly?
This is the honest, nuanced part. Because mitophagy and NAD+ metabolism are both woven into the broader fabric of mitochondrial health, it is biologically plausible that improving one could have downstream effects relevant to the other — healthier mitochondria and better cellular housekeeping don't operate in isolation. Some preclinical work has explored overlapping pathways in mitochondrial maintenance. But plausible is not proven. There is no strong body of human evidence showing that taking urolithin A meaningfully raises measured NAD+ levels, and we are not going to imply otherwise. If someone tells you urolithin A will raise your NAD+, ask them for the human data — because the direct NAD+ story belongs to the precursors, not to urolithin A.
What the human urolithin A trials actually measured
It helps to look at what the studies set out to track, because it was not NAD+. Andreux and colleagues (Nature Metabolism, 2019) established safety up to 1,000 mg/day and found a mitochondrial gene-expression signature in older adults. Singh and colleagues (Cell Reports Medicine, 2022) and Liu/D'Amico and colleagues (JAMA Network Open, 2022) measured muscle endurance and performance over roughly four months. A 2025 Nature Aging randomized controlled trial reported support for immune-cell mitochondrial health in midlife adults. The through-line is mitochondrial function and muscle — not NAD+ concentration. That tells you where urolithin A's evidence genuinely lives.
Should you take both?
Because they work on different parts of the system, some people are curious about combining a NAD+ precursor with urolithin A, and there is no known reason they would conflict — they simply address different things. That said, more is not automatically better, and stacking supplements should be done thoughtfully and ideally with input from a healthcare provider, especially if you take medications or have a medical condition. We cover the pairing question in more detail in our guide on taking urolithin A and NMN together, and the head-to-head in urolithin A vs NMN. If you want the full foundation on urolithin A first, start with the urolithin A guide or compare formats in our best urolithin A gummies roundup.
The honest bottom line
Urolithin A does not boost NAD+, and any product that tells you it does is overselling. NAD+ is raised, as far as current evidence goes, by its precursors like NMN and NR. Urolithin A earns its place through a different mechanism entirely — supporting mitophagy and mitochondrial quality — with early but real human trials focused on muscle and cellular health. Choose based on what you actually want to support, not on the assumption that everything in the longevity aisle does the same job. And remember that none of these compounds treats or cures anything; they are studied as support alongside the basics of exercise, sleep, and diet.
Does urolithin A raise NAD+ levels?
There is no strong human evidence that urolithin A meaningfully raises measured NAD+ levels. It is not a NAD+ precursor and does not get converted into NAD+. Its studied mechanism is mitophagy — the recycling of damaged mitochondria — which is a different pathway entirely.
What is the difference between urolithin A and NMN?
NMN is a direct NAD+ precursor: your body converts it into NAD+ through the salvage pathway. Urolithin A is a food-derived postbiotic studied for inducing mitophagy. One supplies a molecule the cell uses; the other supports the quality of the mitochondria themselves. They address different parts of cellular energy.
If I want to raise NAD+, what should I take?
The compounds most directly associated with raising NAD+ are its precursors, NMN and NR. If raising NAD+ specifically is your goal, those are the researched options — not urolithin A. We'd suggest reading up on each and, if you take medications, checking with a healthcare provider.
Can I take urolithin A and a NAD+ precursor together?
They work on different parts of the system, and there is no known reason they would conflict. But combining supplements should be done thoughtfully, and ideally with guidance from a healthcare provider if you have any medical conditions or take medications. More isn't automatically better.
Why do urolithin A and NAD+ get confused so often?
Both sit in the cellular-energy and longevity space and both relate to mitochondria, so marketing shorthand blurs them together. But the mechanisms are distinct: NAD+ is a coenzyme raised by precursors, while urolithin A is studied for mitochondrial recycling.
Does urolithin A give you energy like a stimulant?
No. It is not a stimulant and does not provide an immediate energy jolt. It is studied for supporting healthy mitochondrial function over weeks and months, which is a slow, foundational process — not a same-day lift. It is also not intended to diagnose, treat, cure, or prevent any disease.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.
A clinically studied 1,000 mg dose of Urolithin A in one simple daily gummy — to support mitophagy, muscle strength, and cellular energy.
Shop SOMA Urolithin A Gummies →